Zoledronic Acid Market 2022 In-depth Analysis by History Review, Dynamics and Growth Factors
Global Zoledronic Acid Market is expected
to grow at a significant CAGR in the upcoming years as the scope, Product
Types, and its applications are increasing across the globe. Zoledronic acid,
or zoledronate, is a bisphosphonate drug to treat diseases pertaining to the
bone. This drug is given intravenously. This zoledronic acid is typically used
for treating bone complications like low bone density. Zoledronic acid is
primarily used to avert bone fracture, hypercalcemia, bone-related indications,
and others. Additionally, it is also used for the treatment of Paget's disease,
and Osteoporosis.
View Summary of This Report @ https://www.millioninsights.com/industry-reports/zoledronic-acid-market
Increase in prevalence of the
diseases like Cancer, the trend of the sedentary lifestyle, increase in obesity
cases and smoking lead to bone complications such as low bone density, bone
fractures, osteoporosis. Additionally, the decrease in strength of the bone in
the geriatric population and rise in the prevalence of osteoporosis in
postmenopausal women are anticipated to increase the demand for zoledronic aid
with the growth of the market.
Besides, the existence of
substitutes for zoledronic acid such as alendronate, denosumab, ibandronate,
and risedronate restrains the market development. Constant R&D activities
with regards to zoledronic acid and rise in consciousness regarding bone
diseases & complications are expected to drive the market growth.
Zoledronic Acid Market is
segmented, By Product Type into Powder, and Injection. Zoledronic Acid Market
is classified based on Application into Pagets Disease, Osteoporosis, Bone
Complications. Zoledronic Acid Market is segmented By Geographical Region into
Asia Pacific (China, India, ASEAN, Australia & New Zealand), Japan, Middle
East and Africa (GCC countries, S. Africa, Rest Of MEA), North America (U.S.,
Canada), Latin America (Brazil, Rest of Latin America), Western Europe
(Germany, Italy, France, England, Spain, Rest of Western Europe), and Eastern
Europe (Poland, Russia, Rest of Eastern Europe).
Zoledronic Acid Market Key
Players include Teva Pharmaceutical Industries Ltd., Emcure Pharmaceuticals,
ScinoPharm Taiwan, LTD., Tecoland Corp., Cipla Ltd.,Mylan Pharms Inc., Hangzhou
Long Shine Bio-Tech, Natco Pharma Ltd., Taj Pharmaceuticals Ltd., and
Lianyungang Runzhong Pharm.
Request a Sample Copy
of This Report @ https://www.millioninsights.com/industry-reports/zoledronic-acid-market/request-sample
Comments
Post a Comment